Login / Signup

SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Natasja van de PolQiuwei PanLauranne A A P DerikxLinda BakkerC Janneke van der WoudeAnnemarie C de Vries
Published in: Therapeutic advances in gastroenterology (2023)
The protocol was published in the PROSPERO database (CRD42021292853).
Keyphrases
  • sars cov
  • patients with inflammatory bowel disease
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • adverse drug
  • coronavirus disease
  • emergency department
  • systematic review